- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Maternal cardiomyopathy may be associated with adverse perinatal outcomes
A new study conducted by Elizabeth Eggleton and team found that there is a high chance of unfavorable perinatal outcomes in pregnancies impacted by maternal cardiomyopathy. The findings of this study were published in the American Journal of Obstetrics & Gynecology.
Heart disease prevalence in pregnancy ranges from 0.3 to 5%. The circulatory alterations that occur during pregnancy in the context of maternal cardiac disease may cause decompensation or death of the mother or fetus. Few prospective studies that specifically addressed cardiac disease in pregnancy and looked at the populations treated at various institutions across the nation are currently available in India. In order to comprehensively evaluate the perinatal outcomes of pregnancies affected by maternal cardiomyopathy, this research was carried out.
From the beginning through August 25th, 2022, PubMed, Ovid EMBASE, Ovid Medline, Cochrane Library, and Clinicaltrials.gov were all thoroughly searched for this study. Pregnant women with cardiomyopathy (of any subtype) and an acceptable control group were included in observational cohort, case-control, and case-cohort studies in human populations if they reported pre-defined perinatal outcomes. Two reviewers separately evaluated each paper for eligibility and bias risk, while a third reviewer arbitrated any disputes. In accordance with PRISMA/MOOSE recommendations, data were extracted and synthesized.
The key findings of this study were:
1. Pregnancies from 13 studies (n = 2,291,024) were eligible for inclusion. Compared to I women with no cardiac illness and (ii) women with other types of cardiac disease, neonates born to mothers with cardiomyopathy had a higher risk of perinatal mortality.
2. Maternal cardiomyopathy dramatically increased the likelihood of preterm delivery and small-for-gestational-age neonates, two main causes of short- and long-term morbidity, during pregnancy when compared to other types of cardiac illness.
In conclusion, if a woman with cardiomyopathy decides to become pregnant, she should receive thorough counseling about the dangers involved and have her pregnancy treated by skilled multidisciplinary teams that can offer close fetal monitoring and neonatology knowledge.
Reference:
Eggleton, E. J., Mcmurrugh, K. J., & Aiken, C. E. (2022). Perinatal outcomes in pregnancies complicated by maternal cardiomyopathy: A systematic review and meta-analysis. In American Journal of Obstetrics and Gynecology. Elsevier BV. https://doi.org/10.1016/j.ajog.2022.09.025
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751